<DOC>
	<DOCNO>NCT01540825</DOCNO>
	<brief_summary>The primary objective current study investigate safety tolerability BI 113608 healthy male volunteer follow oral administration single rise dos . A secondary objective exploration pharmacokinetics BI 113608 single dosing .</brief_summary>
	<brief_title>First Man Trial BI 113608</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male subject Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>